

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 9.62109089 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 9.62109089 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 8.41356574 |
| 4 | protein retention in ER lumen (GO:0006621) | 7.09477627 |
| 5 | signal peptide processing (GO:0006465) | 7.07078238 |
| 6 | ribosomal small subunit biogenesis (GO:0042274) | 6.09168361 |
| 7 | protein maturation by protein folding (GO:0022417) | 6.04805952 |
| 8 | COPII vesicle coating (GO:0048208) | 5.78672013 |
| 9 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.74775844 |
| 10 | positive regulation of nuclease activity (GO:0032075) | 5.66893148 |
| 11 | sequestering of metal ion (GO:0051238) | 5.28654858 |
| 12 | regulation of nuclease activity (GO:0032069) | 5.27875358 |
| 13 | endoplasmic reticulum unfolded protein response (GO:0030968) | 5.08845798 |
| 14 | maturation of SSU-rRNA (GO:0030490) | 5.08216700 |
| 15 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.02211899 |
| 16 | cellular response to unfolded protein (GO:0034620) | 4.96811938 |
| 17 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.95175860 |
| 18 | cellular response to topologically incorrect protein (GO:0035967) | 4.80414091 |
| 19 | ER-nucleus signaling pathway (GO:0006984) | 4.60091457 |
| 20 | exocrine pancreas development (GO:0031017) | 4.48436223 |
| 21 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.45508028 |
| 22 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.37552555 |
| 23 | protein targeting to ER (GO:0045047) | 4.35154175 |
| 24 | cotranslational protein targeting to membrane (GO:0006613) | 4.31027148 |
| 25 | protein N-linked glycosylation via asparagine (GO:0018279) | 4.30529224 |
| 26 | peptidyl-asparagine modification (GO:0018196) | 4.25568237 |
| 27 | response to endoplasmic reticulum stress (GO:0034976) | 4.17298701 |
| 28 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.13813845 |
| 29 | protein localization to endoplasmic reticulum (GO:0070972) | 4.12918516 |
| 30 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.07002836 |
| 31 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.05774020 |
| 32 | ribosomal large subunit biogenesis (GO:0042273) | 4.04318926 |
| 33 | GDP-mannose metabolic process (GO:0019673) | 4.01207573 |
| 34 | viral life cycle (GO:0019058) | 3.93829636 |
| 35 | protein N-linked glycosylation (GO:0006487) | 3.93056066 |
| 36 | ER overload response (GO:0006983) | 3.89173182 |
| 37 | endocrine pancreas development (GO:0031018) | 3.88867133 |
| 38 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.83970859 |
| 39 | * response to unfolded protein (GO:0006986) | 3.81663705 |
| 40 | vesicle coating (GO:0006901) | 3.80997730 |
| 41 | * response to topologically incorrect protein (GO:0035966) | 3.71664186 |
| 42 | cellular protein complex disassembly (GO:0043624) | 3.71294316 |
| 43 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.66173962 |
| 44 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.65983143 |
| 45 | proline biosynthetic process (GO:0006561) | 3.52892148 |
| 46 | peptide hormone processing (GO:0016486) | 3.51124793 |
| 47 | 4-hydroxyproline metabolic process (GO:0019471) | 3.48190491 |
| 48 | cell redox homeostasis (GO:0045454) | 3.40487936 |
| 49 | establishment of integrated proviral latency (GO:0075713) | 3.39068283 |
| 50 | mitotic metaphase plate congression (GO:0007080) | 3.37249212 |
| 51 | chaperone-mediated protein transport (GO:0072321) | 3.36294660 |
| 52 | mitotic chromosome condensation (GO:0007076) | 3.36257284 |
| 53 | glandular epithelial cell differentiation (GO:0002067) | 3.34207761 |
| 54 | DNA deamination (GO:0045006) | 3.31084557 |
| 55 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.27385758 |
| 56 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.19430156 |
| 57 | protein complex disassembly (GO:0043241) | 3.18521683 |
| 58 | establishment of viral latency (GO:0019043) | 3.12152560 |
| 59 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.08733605 |
| 60 | ribosome biogenesis (GO:0042254) | 3.06455370 |
| 61 | rRNA processing (GO:0006364) | 3.00911849 |
| 62 | ribosomal small subunit assembly (GO:0000028) | 2.97808968 |
| 63 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.96861866 |
| 64 | macromolecular complex disassembly (GO:0032984) | 2.96173896 |
| 65 | regulation of mitochondrial translation (GO:0070129) | 2.94545323 |
| 66 | formation of translation preinitiation complex (GO:0001731) | 2.92259701 |
| 67 | chaperone-mediated protein folding (GO:0061077) | 2.91844663 |
| 68 | protein targeting to membrane (GO:0006612) | 2.91567089 |
| 69 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.90794913 |
| 70 | heterochromatin organization (GO:0070828) | 2.90748461 |
| 71 | protein autoprocessing (GO:0016540) | 2.90640374 |
| 72 | tetrahydrofolate metabolic process (GO:0046653) | 2.89344476 |
| 73 | regulation of translational termination (GO:0006449) | 2.88568093 |
| 74 | translation (GO:0006412) | 2.86446790 |
| 75 | regulation of translational fidelity (GO:0006450) | 2.86210743 |
| 76 | maintenance of protein localization in organelle (GO:0072595) | 2.83228650 |
| 77 | ribosome assembly (GO:0042255) | 2.80304661 |
| 78 | cellular component biogenesis (GO:0044085) | 2.78639552 |
| 79 | rRNA metabolic process (GO:0016072) | 2.78386897 |
| 80 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.78011939 |
| 81 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.77167596 |
| 82 | nuclear envelope reassembly (GO:0031468) | 2.76033706 |
| 83 | mitotic nuclear envelope reassembly (GO:0007084) | 2.76033706 |
| 84 | nucleotide-sugar metabolic process (GO:0009225) | 2.74733507 |
| 85 | hemidesmosome assembly (GO:0031581) | 2.72280557 |
| 86 | DNA strand elongation (GO:0022616) | 2.72192318 |
| 87 | protein localization to chromosome, centromeric region (GO:0071459) | 2.71470302 |
| 88 | viral transcription (GO:0019083) | 2.70886619 |
| 89 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.69826675 |
| 90 | DNA unwinding involved in DNA replication (GO:0006268) | 2.69808865 |
| 91 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.69542950 |
| 92 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.68958924 |
| 93 | translational termination (GO:0006415) | 2.68849678 |
| 94 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.68100632 |
| 95 | termination of RNA polymerase III transcription (GO:0006386) | 2.68100632 |
| 96 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.67421428 |
| 97 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.66612440 |
| 98 | proteasome assembly (GO:0043248) | 2.66316966 |
| 99 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.63925088 |
| 100 | maternal placenta development (GO:0001893) | 2.63482795 |
| 101 | negative regulation of ligase activity (GO:0051352) | 2.61568899 |
| 102 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.61568899 |
| 103 | spliceosomal snRNP assembly (GO:0000387) | 2.60592670 |
| 104 | peptide catabolic process (GO:0043171) | 2.60167064 |
| 105 | translational elongation (GO:0006414) | 2.58467201 |
| 106 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.58203354 |
| 107 | protein folding (GO:0006457) | 2.54693946 |
| 108 | mRNA catabolic process (GO:0006402) | 2.53992130 |
| 109 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.53406641 |
| 110 | serine family amino acid biosynthetic process (GO:0009070) | 2.52338396 |
| 111 | cellular protein complex localization (GO:0034629) | 2.51944285 |
| 112 | intestinal cholesterol absorption (GO:0030299) | 2.51067462 |
| 113 | L-serine metabolic process (GO:0006563) | 2.51001253 |
| 114 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.50188719 |
| 115 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.49553696 |
| 116 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.49553696 |
| 117 | pseudouridine synthesis (GO:0001522) | 2.49498314 |
| 118 | cell adhesion mediated by integrin (GO:0033627) | 2.49418249 |
| 119 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.49398568 |
| 120 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.47960006 |
| 121 | metaphase plate congression (GO:0051310) | 2.47631913 |
| 122 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.47195816 |
| 123 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.46508226 |
| 124 | RNA catabolic process (GO:0006401) | 2.44827222 |
| 125 | CENP-A containing nucleosome assembly (GO:0034080) | 2.44758985 |
| 126 | protein targeting to mitochondrion (GO:0006626) | 2.44234272 |
| 127 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.43966263 |
| 128 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.43651879 |
| 129 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.43651879 |
| 130 | rRNA transcription (GO:0009303) | 2.43580731 |
| 131 | translational initiation (GO:0006413) | 2.43369174 |
| 132 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.43190875 |
| 133 | protein carboxylation (GO:0018214) | 2.43190875 |
| 134 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.42447320 |
| 135 | intestinal epithelial cell development (GO:0060576) | 2.42395348 |
| 136 | pinocytosis (GO:0006907) | 2.41877875 |
| 137 | mitochondrial calcium ion transport (GO:0006851) | 2.40943381 |
| 138 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.40024594 |
| 139 | cellular response to glucose starvation (GO:0042149) | 2.39485089 |
| 140 | establishment of protein localization to membrane (GO:0090150) | 2.39442892 |
| 141 | chromatin remodeling at centromere (GO:0031055) | 2.38301946 |
| 142 | regulation of glucokinase activity (GO:0033131) | 2.37756689 |
| 143 | regulation of hexokinase activity (GO:1903299) | 2.37756689 |
| 144 | type B pancreatic cell development (GO:0003323) | 2.37422339 |
| 145 | protein localization to kinetochore (GO:0034501) | 2.36308314 |
| 146 | nucleobase biosynthetic process (GO:0046112) | 2.36085639 |
| 147 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.35999258 |
| 148 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.35566469 |
| 149 | folic acid-containing compound metabolic process (GO:0006760) | 2.35192496 |
| 150 | Golgi organization (GO:0007030) | 2.33780485 |
| 151 | protein complex localization (GO:0031503) | 2.33666765 |
| 152 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.33007598 |
| 153 | skin morphogenesis (GO:0043589) | 2.32877612 |
| 154 | response to testosterone (GO:0033574) | 2.32442809 |
| 155 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.32304972 |
| 156 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.31869112 |
| 157 | glandular epithelial cell development (GO:0002068) | 2.31390065 |
| 158 | pteridine-containing compound metabolic process (GO:0042558) | 2.31006079 |
| 159 | cellular response to vitamin D (GO:0071305) | 2.30342817 |
| 160 | proline metabolic process (GO:0006560) | 2.28999068 |
| 161 | folic acid metabolic process (GO:0046655) | 2.28630759 |
| 162 | peptidyl-proline hydroxylation (GO:0019511) | 2.28145468 |
| 163 | peptidyl-proline modification (GO:0018208) | 2.26985710 |
| 164 | intestinal absorption (GO:0050892) | 2.26615129 |
| 165 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.26442823 |
| 166 | UMP biosynthetic process (GO:0006222) | 2.26442823 |
| 167 | UMP metabolic process (GO:0046049) | 2.26442823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.16585074 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.45604275 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.16764448 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.14975772 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.13950483 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.13754265 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.13580892 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.74855609 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.69706659 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.58484615 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.56722878 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.48818566 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.45007897 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.34701792 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.27600573 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.22380109 |
| 17 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.18267106 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.16464315 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.12007164 |
| 20 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.07966432 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.95765511 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.93758588 |
| 23 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.92216292 |
| 24 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.91526900 |
| 25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.91005253 |
| 26 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.90727059 |
| 27 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.89189608 |
| 28 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.88793502 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.85572650 |
| 30 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84277652 |
| 31 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82336708 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.82147337 |
| 33 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.76073748 |
| 34 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.74395272 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.67741684 |
| 36 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.64425366 |
| 37 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.64201764 |
| 38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.63155306 |
| 39 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.58206492 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.58140705 |
| 41 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55685967 |
| 42 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.54390435 |
| 43 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52958829 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52474528 |
| 45 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.52447597 |
| 46 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50440022 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.50434115 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49586784 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.49294764 |
| 50 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.48915339 |
| 51 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.44102307 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43865860 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43611565 |
| 54 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.42260243 |
| 55 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.41492645 |
| 56 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.40678460 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40640186 |
| 58 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.38306468 |
| 59 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.34665491 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34629405 |
| 61 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.33948816 |
| 62 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.33158194 |
| 63 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.32457698 |
| 64 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.31785171 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.31352884 |
| 66 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30883356 |
| 67 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30818746 |
| 68 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29801355 |
| 69 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.27972309 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25999662 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24636497 |
| 72 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.24359661 |
| 73 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.23898153 |
| 74 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23322483 |
| 75 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.22584557 |
| 76 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21280068 |
| 77 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.19964711 |
| 78 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.19353768 |
| 79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17922964 |
| 80 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.17855064 |
| 81 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.16728280 |
| 82 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16482893 |
| 83 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.14675229 |
| 84 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.13069598 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12750099 |
| 86 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.12512113 |
| 87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12142666 |
| 88 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.11878497 |
| 89 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.09782332 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08948497 |
| 91 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08813712 |
| 92 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08484920 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07825598 |
| 94 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07102106 |
| 95 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.06773199 |
| 96 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06521257 |
| 97 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06148828 |
| 98 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05950363 |
| 99 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.05817671 |
| 100 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.05472749 |
| 101 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.05375464 |
| 102 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.03845844 |
| 103 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.03845844 |
| 104 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.03845844 |
| 105 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.02006021 |
| 106 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.01667806 |
| 107 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.01420511 |
| 108 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01273085 |
| 109 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.01142098 |
| 110 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.00906144 |
| 111 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00896637 |
| 112 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.99211050 |
| 113 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99173999 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98453113 |
| 115 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98310107 |
| 116 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97978394 |
| 117 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.96971223 |
| 118 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.96659816 |
| 119 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.96442605 |
| 120 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.96095471 |
| 121 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.95121165 |
| 122 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94818985 |
| 123 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94478199 |
| 124 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93461839 |
| 125 | ATF3_27146783_Chip-Seq_COLON_Human | 0.93192007 |
| 126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92913957 |
| 127 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.92485996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 3.67101408 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.36867969 |
| 3 | MP0005220_abnormal_exocrine_pancreas | 3.21174606 |
| 4 | MP0003941_abnormal_skin_development | 3.07579713 |
| 5 | MP0002693_abnormal_pancreas_physiology | 2.80710040 |
| 6 | MP0009379_abnormal_foot_pigmentation | 2.75186922 |
| 7 | MP0006054_spinal_hemorrhage | 2.72300560 |
| 8 | MP0001944_abnormal_pancreas_morphology | 2.67566645 |
| 9 | MP0003195_calcinosis | 2.46112367 |
| 10 | MP0003283_abnormal_digestive_organ | 2.39131604 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.35220713 |
| 12 | MP0005365_abnormal_bile_salt | 2.04909731 |
| 13 | MP0004272_abnormal_basement_membrane | 1.99269250 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 1.99141255 |
| 15 | MP0004043_abnormal_pH_regulation | 1.96742975 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 1.96265699 |
| 17 | MP0003183_abnormal_peptide_metabolism | 1.95065255 |
| 18 | MP0000678_abnormal_parathyroid_gland | 1.94259411 |
| 19 | MP0009053_abnormal_anal_canal | 1.89400490 |
| 20 | MP0003300_gastrointestinal_ulcer | 1.86966530 |
| 21 | MP0002796_impaired_skin_barrier | 1.86049179 |
| 22 | MP0010030_abnormal_orbit_morphology | 1.85318446 |
| 23 | MP0001666_abnormal_nutrient_absorption | 1.83480712 |
| 24 | MP0005451_abnormal_body_composition | 1.82913620 |
| 25 | MP0000013_abnormal_adipose_tissue | 1.81558003 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.80717210 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 1.70894526 |
| 28 | MP0001849_ear_inflammation | 1.70141312 |
| 29 | MP0005083_abnormal_biliary_tract | 1.68680713 |
| 30 | MP0010234_abnormal_vibrissa_follicle | 1.68453980 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.66574600 |
| 32 | MP0003453_abnormal_keratinocyte_physiol | 1.61271129 |
| 33 | MP0004858_abnormal_nervous_system | 1.60041563 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.57547790 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.57534405 |
| 36 | MP0005501_abnormal_skin_physiology | 1.49834415 |
| 37 | MP0003868_abnormal_feces_composition | 1.44851036 |
| 38 | MP0010094_abnormal_chromosome_stability | 1.44061549 |
| 39 | MP0005379_endocrine/exocrine_gland_phen | 1.43975090 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.42876732 |
| 41 | MP0010352_gastrointestinal_tract_polyps | 1.40693831 |
| 42 | MP0005623_abnormal_meninges_morphology | 1.39484117 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.34954738 |
| 44 | MP0000762_abnormal_tongue_morphology | 1.34631330 |
| 45 | MP0002078_abnormal_glucose_homeostasis | 1.34475935 |
| 46 | MP0003186_abnormal_redox_activity | 1.34299521 |
| 47 | MP0010386_abnormal_urinary_bladder | 1.33174495 |
| 48 | MP0003252_abnormal_bile_duct | 1.32941720 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.31108659 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.30746469 |
| 51 | MP0000613_abnormal_salivary_gland | 1.30083915 |
| 52 | MP0002928_abnormal_bile_duct | 1.29368737 |
| 53 | MP0000579_abnormal_nail_morphology | 1.29135634 |
| 54 | MP0003315_abnormal_perineum_morphology | 1.29053433 |
| 55 | MP0000537_abnormal_urethra_morphology | 1.25522072 |
| 56 | MP0005084_abnormal_gallbladder_morpholo | 1.25000302 |
| 57 | MP0003436_decreased_susceptibility_to | 1.24396162 |
| 58 | MP0005085_abnormal_gallbladder_physiolo | 1.23797803 |
| 59 | MP0001216_abnormal_epidermal_layer | 1.19683831 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.18881669 |
| 61 | MP0005408_hypopigmentation | 1.18726690 |
| 62 | MP0001853_heart_inflammation | 1.18494596 |
| 63 | MP0002896_abnormal_bone_mineralization | 1.15354381 |
| 64 | MP0003718_maternal_effect | 1.15026895 |
| 65 | MP0009333_abnormal_splenocyte_physiolog | 1.13940442 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 1.09627224 |
| 67 | MP0000858_altered_metastatic_potential | 1.09585511 |
| 68 | MP0009780_abnormal_chondrocyte_physiolo | 1.08898341 |
| 69 | MP0001881_abnormal_mammary_gland | 1.08768998 |
| 70 | MP0009697_abnormal_copulation | 1.07899942 |
| 71 | MP0008007_abnormal_cellular_replicative | 1.06751053 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 1.05591344 |
| 73 | MP0001672_abnormal_embryogenesis/_devel | 1.04764950 |
| 74 | MP0005380_embryogenesis_phenotype | 1.04764950 |
| 75 | MP0002254_reproductive_system_inflammat | 1.04164096 |
| 76 | MP0005360_urolithiasis | 1.03638399 |
| 77 | MP0000627_abnormal_mammary_gland | 1.02745460 |
| 78 | MP0000490_abnormal_crypts_of | 1.01596372 |
| 79 | MP0000003_abnormal_adipose_tissue | 1.00107091 |
| 80 | MP0001756_abnormal_urination | 0.99075484 |
| 81 | MP0000609_abnormal_liver_physiology | 0.98380378 |
| 82 | MP0002089_abnormal_postnatal_growth/wei | 0.96155114 |
| 83 | MP0003984_embryonic_growth_retardation | 0.94828054 |
| 84 | MP0001845_abnormal_inflammatory_respons | 0.94761828 |
| 85 | MP0003959_abnormal_lean_body | 0.92197456 |
| 86 | MP0009840_abnormal_foam_cell | 0.91574455 |
| 87 | MP0000467_abnormal_esophagus_morphology | 0.91510061 |
| 88 | MP0000313_abnormal_cell_death | 0.91283662 |
| 89 | MP0003795_abnormal_bone_structure | 0.90925921 |
| 90 | MP0000598_abnormal_liver_morphology | 0.90701480 |
| 91 | MP0004233_abnormal_muscle_weight | 0.90133430 |
| 92 | MP0002085_abnormal_embryonic_tissue | 0.90038964 |
| 93 | MP0001533_abnormal_skeleton_physiology | 0.89937722 |
| 94 | MP0003077_abnormal_cell_cycle | 0.88911913 |
| 95 | MP0002088_abnormal_embryonic_growth/wei | 0.88902877 |
| 96 | MP0003866_abnormal_defecation | 0.88022682 |
| 97 | MP0005197_abnormal_uvea_morphology | 0.87503897 |
| 98 | MP0003123_paternal_imprinting | 0.87028561 |
| 99 | MP0003890_abnormal_embryonic-extraembry | 0.85321720 |
| 100 | MP0008932_abnormal_embryonic_tissue | 0.84830760 |
| 101 | MP0002086_abnormal_extraembryonic_tissu | 0.84791539 |
| 102 | MP0005257_abnormal_intraocular_pressure | 0.84558705 |
| 103 | MP0001764_abnormal_homeostasis | 0.84380399 |
| 104 | MP0005319_abnormal_enzyme/_coenzyme | 0.84257231 |
| 105 | MP0003724_increased_susceptibility_to | 0.83927691 |
| 106 | MP0001765_abnormal_ion_homeostasis | 0.83798508 |
| 107 | MP0003303_peritoneal_inflammation | 0.82408335 |
| 108 | MP0003448_altered_tumor_morphology | 0.80883850 |
| 109 | MP0005310_abnormal_salivary_gland | 0.80554034 |
| 110 | MP0003091_abnormal_cell_migration | 0.79763690 |
| 111 | MP0003950_abnormal_plasma_membrane | 0.79508999 |
| 112 | MP0009672_abnormal_birth_weight | 0.79113950 |
| 113 | MP0000358_abnormal_cell_content/ | 0.79041644 |
| 114 | MP0001730_embryonic_growth_arrest | 0.78899328 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.78188749 |
| 116 | MP0005023_abnormal_wound_healing | 0.78074842 |
| 117 | MP0000462_abnormal_digestive_system | 0.77680903 |
| 118 | MP0000566_synostosis | 0.76810240 |
| 119 | MP0000343_altered_response_to | 0.76655227 |
| 120 | MP0001542_abnormal_bone_strength | 0.76358662 |
| 121 | MP0002697_abnormal_eye_size | 0.76203981 |
| 122 | MP0008469_abnormal_protein_level | 0.75871288 |
| 123 | MP0002111_abnormal_tail_morphology | 0.75285351 |
| 124 | MP0008058_abnormal_DNA_repair | 0.75246551 |
| 125 | MP0009931_abnormal_skin_appearance | 0.74894916 |
| 126 | MP0001243_abnormal_dermal_layer | 0.74730517 |
| 127 | MP0001915_intracranial_hemorrhage | 0.74203480 |
| 128 | MP0002084_abnormal_developmental_patter | 0.73605352 |
| 129 | MP0005621_abnormal_cell_physiology | 0.72930619 |
| 130 | MP0003279_aneurysm | 0.71711261 |
| 131 | MP0010307_abnormal_tumor_latency | 0.71581343 |
| 132 | MP0003786_premature_aging | 0.71353154 |
| 133 | MP0005275_abnormal_skin_tensile | 0.71320142 |
| 134 | MP0005332_abnormal_amino_acid | 0.70551136 |
| 135 | MP0003953_abnormal_hormone_level | 0.70020384 |
| 136 | MP0000685_abnormal_immune_system | 0.69915061 |
| 137 | MP0003385_abnormal_body_wall | 0.69766282 |
| 138 | MP0004947_skin_inflammation | 0.68607105 |
| 139 | MP0008260_abnormal_autophagy | 0.68517596 |
| 140 | MP0010155_abnormal_intestine_physiology | 0.68300891 |
| 141 | MP0005508_abnormal_skeleton_morphology | 0.67981323 |
| 142 | MP0002080_prenatal_lethality | 0.67375773 |
| 143 | MP0005389_reproductive_system_phenotype | 0.67174619 |
| 144 | MP0003111_abnormal_nucleus_morphology | 0.64669454 |
| 145 | MP0000350_abnormal_cell_proliferation | 0.63934072 |
| 146 | MP0009642_abnormal_blood_homeostasis | 0.63540949 |
| 147 | MP0002160_abnormal_reproductive_system | 0.62886779 |
| 148 | MP0006036_abnormal_mitochondrial_physio | 0.62641998 |
| 149 | MP0002019_abnormal_tumor_incidence | 0.62497073 |
| 150 | MP0002060_abnormal_skin_morphology | 0.61976956 |
| 151 | MP0005390_skeleton_phenotype | 0.61047541 |
| 152 | MP0002166_altered_tumor_susceptibility | 0.60725616 |
| 153 | MP0001697_abnormal_embryo_size | 0.60398391 |
| 154 | MP0005000_abnormal_immune_tolerance | 0.59521096 |
| 155 | MP0003172_abnormal_lysosome_physiology | 0.59451137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 5.62273458 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.31603595 |
| 3 | Hypoglycemic seizures (HP:0002173) | 5.13254922 |
| 4 | Abnormality of the intrinsic pathway (HP:0010989) | 4.42590461 |
| 5 | Symptomatic seizures (HP:0011145) | 4.37591210 |
| 6 | Late onset (HP:0003584) | 3.71031516 |
| 7 | Oral leukoplakia (HP:0002745) | 3.64302612 |
| 8 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.59039083 |
| 9 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.59039083 |
| 10 | Generalized aminoaciduria (HP:0002909) | 3.52824677 |
| 11 | Hyperglycemia (HP:0003074) | 3.49489009 |
| 12 | Abnormal glycosylation (HP:0012345) | 3.42813052 |
| 13 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.42813052 |
| 14 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.42813052 |
| 15 | Abnormal protein glycosylation (HP:0012346) | 3.42813052 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.31389833 |
| 17 | Rough bone trabeculation (HP:0100670) | 3.30598522 |
| 18 | Mucopolysacchariduria (HP:0008155) | 3.28366545 |
| 19 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.28366545 |
| 20 | Type I transferrin isoform profile (HP:0003642) | 3.26416419 |
| 21 | Deep venous thrombosis (HP:0002625) | 3.19029394 |
| 22 | Dysostosis multiplex (HP:0000943) | 3.17510304 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.15544172 |
| 24 | Abnormal pancreas size (HP:0012094) | 3.12251443 |
| 25 | Macrocytic anemia (HP:0001972) | 3.09432532 |
| 26 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.08070508 |
| 27 | Degeneration of anterior horn cells (HP:0002398) | 3.06730058 |
| 28 | Abnormality of the anterior horn cell (HP:0006802) | 3.06730058 |
| 29 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.04807905 |
| 30 | Thrombocytosis (HP:0001894) | 3.04754382 |
| 31 | Ketoacidosis (HP:0001993) | 3.02580486 |
| 32 | Achilles tendon contracture (HP:0001771) | 3.02314942 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.99288029 |
| 34 | Abnormality of the Achilles tendon (HP:0005109) | 2.95416892 |
| 35 | Selective tooth agenesis (HP:0001592) | 2.94530504 |
| 36 | Insulin resistance (HP:0000855) | 2.94286574 |
| 37 | Abnormal trabecular bone morphology (HP:0100671) | 2.83233557 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 2.82676569 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.80625430 |
| 40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.80625430 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.80625430 |
| 42 | Thoracolumbar scoliosis (HP:0002944) | 2.75654160 |
| 43 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.73579639 |
| 44 | Atrophic scars (HP:0001075) | 2.52639619 |
| 45 | Fragile skin (HP:0001030) | 2.49483039 |
| 46 | Beaking of vertebral bodies (HP:0004568) | 2.48867035 |
| 47 | Sparse eyelashes (HP:0000653) | 2.46386871 |
| 48 | Poor head control (HP:0002421) | 2.44601273 |
| 49 | Aplastic anemia (HP:0001915) | 2.39066437 |
| 50 | Prominent metopic ridge (HP:0005487) | 2.35449340 |
| 51 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.35444755 |
| 52 | Large for gestational age (HP:0001520) | 2.33181347 |
| 53 | Exocrine pancreatic insufficiency (HP:0001738) | 2.26791612 |
| 54 | Short nail (HP:0001799) | 2.25974021 |
| 55 | Abnormality of carpal bone ossification (HP:0006257) | 2.25690156 |
| 56 | 11 pairs of ribs (HP:0000878) | 2.21286583 |
| 57 | Ankle contracture (HP:0006466) | 2.21067050 |
| 58 | Ketosis (HP:0001946) | 2.20858713 |
| 59 | Flat acetabular roof (HP:0003180) | 2.20817050 |
| 60 | Abdominal distention (HP:0003270) | 2.19468607 |
| 61 | Blue sclerae (HP:0000592) | 2.18282649 |
| 62 | Abnormality of dentin (HP:0010299) | 2.16029710 |
| 63 | Multiple enchondromatosis (HP:0005701) | 2.08311657 |
| 64 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.07727227 |
| 65 | Cervical subluxation (HP:0003308) | 2.05663262 |
| 66 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.05172339 |
| 67 | Vertebral compression fractures (HP:0002953) | 2.04404437 |
| 68 | Abnormality of T cell physiology (HP:0011840) | 2.04158203 |
| 69 | Pallor (HP:0000980) | 2.04102540 |
| 70 | Microvesicular hepatic steatosis (HP:0001414) | 2.02794618 |
| 71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01268837 |
| 72 | Osteolytic defects of the hand bones (HP:0009699) | 2.01268837 |
| 73 | Nonimmune hydrops fetalis (HP:0001790) | 2.00803400 |
| 74 | Hyperparathyroidism (HP:0000843) | 2.00768049 |
| 75 | Increased hepatocellular lipid droplets (HP:0006565) | 2.00695902 |
| 76 | Fragile nails (HP:0001808) | 2.00667457 |
| 77 | Abnormality of the umbilical cord (HP:0010881) | 1.99451636 |
| 78 | Progressive muscle weakness (HP:0003323) | 1.99436592 |
| 79 | Spinal cord compression (HP:0002176) | 1.95437709 |
| 80 | Unilateral renal agenesis (HP:0000122) | 1.95395504 |
| 81 | Amniotic constriction ring (HP:0009775) | 1.94227011 |
| 82 | Abnormality of placental membranes (HP:0011409) | 1.94227011 |
| 83 | Elbow flexion contracture (HP:0002987) | 1.92971050 |
| 84 | Trismus (HP:0000211) | 1.92935774 |
| 85 | Acute necrotizing encephalopathy (HP:0006965) | 1.92880974 |
| 86 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.91999634 |
| 87 | Hypoplasia of the pons (HP:0012110) | 1.91300848 |
| 88 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.91180461 |
| 89 | Onycholysis (HP:0001806) | 1.90528689 |
| 90 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.90186518 |
| 91 | Protrusio acetabuli (HP:0003179) | 1.90172917 |
| 92 | Abnormal number of erythroid precursors (HP:0012131) | 1.90150544 |
| 93 | Gout (HP:0001997) | 1.90042682 |
| 94 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.89846355 |
| 95 | Progressive neurologic deterioration (HP:0002344) | 1.89275367 |
| 96 | Joint stiffness (HP:0001387) | 1.88893700 |
| 97 | Missing ribs (HP:0000921) | 1.87729892 |
| 98 | Chronic bronchitis (HP:0004469) | 1.87269141 |
| 99 | Abnormal ossification of hand bones (HP:0005921) | 1.86823347 |
| 100 | Microretrognathia (HP:0000308) | 1.86384397 |
| 101 | Elevated alkaline phosphatase (HP:0003155) | 1.85721090 |
| 102 | Natal tooth (HP:0000695) | 1.85501323 |
| 103 | Abnormal tarsal ossification (HP:0008369) | 1.85354509 |
| 104 | Premature rupture of membranes (HP:0001788) | 1.84363011 |
| 105 | Fat malabsorption (HP:0002630) | 1.84208365 |
| 106 | Abnormality of the metopic suture (HP:0005556) | 1.83829987 |
| 107 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.83817192 |
| 108 | Acute encephalopathy (HP:0006846) | 1.83784387 |
| 109 | Decreased subcutaneous fat (HP:0001002) | 1.83702755 |
| 110 | Abnormality of urine glucose concentration (HP:0011016) | 1.83377156 |
| 111 | Glycosuria (HP:0003076) | 1.83377156 |
| 112 | Delayed cranial suture closure (HP:0000270) | 1.83297492 |
| 113 | Long palpebral fissure (HP:0000637) | 1.83188248 |
| 114 | Severe short stature (HP:0003510) | 1.82372780 |
| 115 | Intrahepatic cholestasis (HP:0001406) | 1.81706518 |
| 116 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.81019893 |
| 117 | Deviation of the thumb (HP:0009603) | 1.79261271 |
| 118 | Prolonged partial thromboplastin time (HP:0003645) | 1.78841701 |
| 119 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77829490 |
| 120 | Abnormality of the acetabulum (HP:0003170) | 1.77741794 |
| 121 | Type I diabetes mellitus (HP:0100651) | 1.77140448 |
| 122 | Ridged nail (HP:0001807) | 1.75236265 |
| 123 | Renal Fanconi syndrome (HP:0001994) | 1.75065980 |
| 124 | Secondary amenorrhea (HP:0000869) | 1.74288774 |
| 125 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.74026219 |
| 126 | Vertebral hypoplasia (HP:0008417) | 1.74026219 |
| 127 | Decreased circulating renin level (HP:0003351) | 1.72781043 |
| 128 | Lipid accumulation in hepatocytes (HP:0006561) | 1.72491779 |
| 129 | Abnormality of purine metabolism (HP:0004352) | 1.72228973 |
| 130 | Cerebral edema (HP:0002181) | 1.71749295 |
| 131 | Abnormal hemoglobin (HP:0011902) | 1.71489003 |
| 132 | Pancreatitis (HP:0001733) | 1.70125610 |
| 133 | Testicular atrophy (HP:0000029) | 1.69415369 |
| 134 | Hyperphosphaturia (HP:0003109) | 1.69115880 |
| 135 | Conjugated hyperbilirubinemia (HP:0002908) | 1.68847803 |
| 136 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.68384370 |
| 137 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.66562542 |
| 138 | Protuberant abdomen (HP:0001538) | 1.66492374 |
| 139 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.65900950 |
| 140 | Patent foramen ovale (HP:0001655) | 1.65506458 |
| 141 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.65396592 |
| 142 | Single umbilical artery (HP:0001195) | 1.65396592 |
| 143 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.65396592 |
| 144 | Nasolacrimal duct obstruction (HP:0000579) | 1.64991496 |
| 145 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.64969114 |
| 146 | Abnormality of the pons (HP:0007361) | 1.64963491 |
| 147 | Pterygium (HP:0001059) | 1.64880532 |
| 148 | Generalized amyotrophy (HP:0003700) | 1.64386223 |
| 149 | Ankyloglossia (HP:0010296) | 1.64173289 |
| 150 | Abnormal foot bone ossification (HP:0010675) | 1.64169173 |
| 151 | Abnormality of complement system (HP:0005339) | 1.62439063 |
| 152 | Dysautonomia (HP:0002459) | 1.62417017 |
| 153 | Milia (HP:0001056) | 1.60947363 |
| 154 | Villous atrophy (HP:0011473) | 1.60312870 |
| 155 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.60312870 |
| 156 | Hepatic necrosis (HP:0002605) | 1.59027181 |
| 157 | Glossoptosis (HP:0000162) | 1.58233911 |
| 158 | Back pain (HP:0003418) | 1.57857038 |
| 159 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.57125707 |
| 160 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.57125707 |
| 161 | Reticulocytopenia (HP:0001896) | 1.57079045 |
| 162 | Abnormality of glycolipid metabolism (HP:0010969) | 1.57063091 |
| 163 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.57063091 |
| 164 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.57063091 |
| 165 | Abnormal delivery (HP:0001787) | 1.56680709 |
| 166 | Pseudobulbar signs (HP:0002200) | 1.56207183 |
| 167 | Irregular vertebral endplates (HP:0003301) | 1.55196864 |
| 168 | Abnormal cartilage morphology (HP:0002763) | 1.53889991 |
| 169 | Upper motor neuron abnormality (HP:0002127) | 1.53770189 |
| 170 | Overlapping toe (HP:0001845) | 1.52709052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.77511614 |
| 2 | PASK | 4.07874196 |
| 3 | VRK2 | 2.96804133 |
| 4 | INSRR | 2.88320088 |
| 5 | EIF2AK3 | 2.85014167 |
| 6 | TAOK3 | 2.64355128 |
| 7 | BCKDK | 2.63670432 |
| 8 | PBK | 2.58987122 |
| 9 | SMG1 | 2.54944716 |
| 10 | FLT3 | 2.45076272 |
| 11 | NME2 | 2.40803755 |
| 12 | SCYL2 | 2.29659670 |
| 13 | TESK1 | 2.25319712 |
| 14 | MAPK15 | 2.24584048 |
| 15 | EIF2AK1 | 2.22116451 |
| 16 | ARAF | 2.12713705 |
| 17 | TRIB3 | 2.11109239 |
| 18 | FRK | 2.01846836 |
| 19 | NEK1 | 1.93808880 |
| 20 | IRAK3 | 1.90960000 |
| 21 | PRPF4B | 1.82372774 |
| 22 | BRSK2 | 1.73994453 |
| 23 | TAOK2 | 1.67050761 |
| 24 | TESK2 | 1.64939192 |
| 25 | LATS2 | 1.62377975 |
| 26 | TTK | 1.61301727 |
| 27 | HIPK2 | 1.53840518 |
| 28 | PKN2 | 1.52902428 |
| 29 | BUB1 | 1.51973898 |
| 30 | RPS6KA4 | 1.49326301 |
| 31 | STK16 | 1.45107734 |
| 32 | PIM2 | 1.44046930 |
| 33 | MST1R | 1.41920707 |
| 34 | DYRK3 | 1.32886307 |
| 35 | WEE1 | 1.31215090 |
| 36 | EPHA2 | 1.28222157 |
| 37 | EPHB2 | 1.27423097 |
| 38 | MOS | 1.24336497 |
| 39 | PTK6 | 1.20090695 |
| 40 | STK24 | 1.19936923 |
| 41 | VRK1 | 1.18199348 |
| 42 | PIK3CG | 1.15633646 |
| 43 | IRAK4 | 1.11798939 |
| 44 | MAP2K2 | 1.10577200 |
| 45 | MAP3K9 | 1.10079033 |
| 46 | MAPKAPK3 | 1.07944830 |
| 47 | KDR | 1.03607844 |
| 48 | ABL2 | 1.03056514 |
| 49 | ERBB4 | 1.02542785 |
| 50 | MAP3K3 | 1.01876863 |
| 51 | STK4 | 0.98786772 |
| 52 | ICK | 0.97397720 |
| 53 | CDK12 | 0.97314191 |
| 54 | RPS6KB2 | 0.97160508 |
| 55 | ZAP70 | 0.96285498 |
| 56 | TLK1 | 0.94856793 |
| 57 | CHEK2 | 0.94856272 |
| 58 | JAK3 | 0.92433374 |
| 59 | MAP3K11 | 0.92408107 |
| 60 | LRRK2 | 0.91598980 |
| 61 | TAF1 | 0.88436290 |
| 62 | ACVR1B | 0.86084700 |
| 63 | DYRK1B | 0.85531486 |
| 64 | MAP3K10 | 0.85014390 |
| 65 | TBK1 | 0.84823778 |
| 66 | CDK4 | 0.82553846 |
| 67 | IRAK1 | 0.81205297 |
| 68 | TEC | 0.80954809 |
| 69 | MAP3K8 | 0.80679456 |
| 70 | PAK4 | 0.78527868 |
| 71 | BTK | 0.77522178 |
| 72 | DDR2 | 0.77215432 |
| 73 | NEK9 | 0.76998960 |
| 74 | PRKD3 | 0.76664545 |
| 75 | MAP3K13 | 0.75995626 |
| 76 | MAP3K14 | 0.74511715 |
| 77 | NEK2 | 0.73582977 |
| 78 | BRAF | 0.72823524 |
| 79 | MAP3K2 | 0.72015711 |
| 80 | CDK8 | 0.71641685 |
| 81 | PDGFRA | 0.71511531 |
| 82 | EEF2K | 0.70722966 |
| 83 | MST4 | 0.69210053 |
| 84 | EPHA3 | 0.68629465 |
| 85 | BRSK1 | 0.68031676 |
| 86 | AURKB | 0.66939989 |
| 87 | NME1 | 0.66874674 |
| 88 | PTK2 | 0.65162064 |
| 89 | PLK3 | 0.64525333 |
| 90 | CHEK1 | 0.64257285 |
| 91 | CDK7 | 0.63086049 |
| 92 | TYK2 | 0.61766781 |
| 93 | LIMK1 | 0.61204778 |
| 94 | CDC7 | 0.61049629 |
| 95 | MAP3K12 | 0.60701141 |
| 96 | DAPK3 | 0.60492497 |
| 97 | PRKCI | 0.60253983 |
| 98 | STK10 | 0.60059237 |
| 99 | AURKA | 0.59587722 |
| 100 | MET | 0.59062088 |
| 101 | SRPK1 | 0.57838994 |
| 102 | NLK | 0.57114127 |
| 103 | MAP3K1 | 0.56537769 |
| 104 | PLK4 | 0.55893372 |
| 105 | LATS1 | 0.52538558 |
| 106 | FGFR4 | 0.52119986 |
| 107 | SIK1 | 0.51625724 |
| 108 | MAP2K3 | 0.49943981 |
| 109 | PLK1 | 0.49643260 |
| 110 | MAP4K1 | 0.49360073 |
| 111 | TAOK1 | 0.47134657 |
| 112 | LMTK2 | 0.46887389 |
| 113 | ALK | 0.46803447 |
| 114 | PDK2 | 0.45904038 |
| 115 | TGFBR1 | 0.45467717 |
| 116 | CAMK1D | 0.45168953 |
| 117 | PAK2 | 0.45002942 |
| 118 | AKT3 | 0.44099622 |
| 119 | CAMKK2 | 0.44014806 |
| 120 | ILK | 0.43098140 |
| 121 | TGFBR2 | 0.43056787 |
| 122 | WNK4 | 0.43020487 |
| 123 | ZAK | 0.42393774 |
| 124 | PIM1 | 0.41887172 |
| 125 | CLK1 | 0.41694297 |
| 126 | STK3 | 0.40860235 |
| 127 | DMPK | 0.40785510 |
| 128 | BLK | 0.40481018 |
| 129 | CSNK2A1 | 0.40237340 |
| 130 | TSSK6 | 0.39295738 |
| 131 | CDK6 | 0.38052971 |
| 132 | MAPKAPK2 | 0.37786934 |
| 133 | ATR | 0.37370573 |
| 134 | CSNK2A2 | 0.36613818 |
| 135 | CHUK | 0.36423065 |
| 136 | PAK1 | 0.35718749 |
| 137 | CSK | 0.35591249 |
| 138 | PRKG2 | 0.35249579 |
| 139 | JAK2 | 0.35156062 |
| 140 | ITK | 0.35078729 |
| 141 | MTOR | 0.32658232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 6.88349546 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.79177627 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 4.18132261 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.62344194 |
| 5 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.55792914 |
| 6 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.34223657 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.17003467 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.13001177 |
| 9 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.04185116 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.00236630 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.92879382 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 1.82500528 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.64882533 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.59921052 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.59274324 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.56108873 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.42484412 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.39593643 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.38846753 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.30086340 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.27070388 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25738876 |
| 23 | Galactose metabolism_Homo sapiens_hsa00052 | 1.22017948 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20014677 |
| 25 | Mismatch repair_Homo sapiens_hsa03430 | 1.18853333 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.16783293 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.16241397 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.15130988 |
| 29 | Spliceosome_Homo sapiens_hsa03040 | 1.12426166 |
| 30 | RNA transport_Homo sapiens_hsa03013 | 1.09379863 |
| 31 | Base excision repair_Homo sapiens_hsa03410 | 1.09077340 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06471305 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05674147 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.05222133 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.05117496 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04262378 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01703850 |
| 38 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.98504368 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.96281447 |
| 40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.95740778 |
| 41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.90884772 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.88026842 |
| 43 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.86757173 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84323661 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80515999 |
| 46 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.80309234 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77215296 |
| 48 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71626483 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71359352 |
| 50 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71222868 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69994853 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69984257 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69956779 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66929058 |
| 55 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66921794 |
| 56 | Homologous recombination_Homo sapiens_hsa03440 | 0.65903499 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64235347 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61972874 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61468237 |
| 60 | Cell cycle_Homo sapiens_hsa04110 | 0.61268840 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59931266 |
| 62 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59467758 |
| 63 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58333187 |
| 64 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58267215 |
| 65 | Bladder cancer_Homo sapiens_hsa05219 | 0.58038768 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57971601 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.57844737 |
| 68 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57527431 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57401247 |
| 70 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57386462 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56669594 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56532860 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56244150 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.56114829 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56104330 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55348147 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54587529 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53739118 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52537424 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50634623 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50285859 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49680202 |
| 83 | Purine metabolism_Homo sapiens_hsa00230 | 0.49586838 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49244605 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47201722 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46538076 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45792006 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45564849 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44522877 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43955077 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43440425 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43120247 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42999853 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42705186 |
| 95 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42589099 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42074158 |
| 97 | RNA degradation_Homo sapiens_hsa03018 | 0.41466140 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41176392 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.39739528 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39149219 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38740675 |
| 102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.38695179 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37839135 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37398327 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36713265 |
| 106 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.35931053 |
| 107 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.35284338 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.35050567 |
| 109 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34084619 |
| 110 | Insulin secretion_Homo sapiens_hsa04911 | 0.32989442 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.32906402 |
| 112 | Carbon metabolism_Homo sapiens_hsa01200 | 0.32880549 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32385657 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.32075636 |
| 115 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31993530 |
| 116 | Peroxisome_Homo sapiens_hsa04146 | 0.30448908 |
| 117 | Basal transcription factors_Homo sapiens_hsa03022 | 0.29853780 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28803064 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.28448590 |
| 120 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.27616294 |
| 121 | Prostate cancer_Homo sapiens_hsa05215 | 0.26609819 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25881162 |
| 123 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24802893 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23924932 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.23842687 |
| 126 | Pertussis_Homo sapiens_hsa05133 | 0.23074553 |
| 127 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.21428389 |
| 128 | Leishmaniasis_Homo sapiens_hsa05140 | 0.20750173 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.20649133 |
| 130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19348769 |

